
Relation Therapeutics is an end-to-end biotech company focused on developing transformational medicines by leveraging high-resolution biology, machine learning, and clinical insights. Their core technology, the Lab-in-the-Loop, integrates single-cell analysis, genomics, and machine learning to understand human biology and discover therapies for devastating diseases. The company, founded in January 2020, has secured significant funding, including a $60M seed round and a strategic partnership with GSK, and is actively seeking world-class talent across biology, machine learning, and drug discovery.

Relation Therapeutics is an end-to-end biotech company focused on developing transformational medicines by leveraging high-resolution biology, machine learning, and clinical insights. Their core technology, the Lab-in-the-Loop, integrates single-cell analysis, genomics, and machine learning to understand human biology and discover therapies for devastating diseases. The company, founded in January 2020, has secured significant funding, including a $60M seed round and a strategic partnership with GSK, and is actively seeking world-class talent across biology, machine learning, and drug discovery.
What they do: End-to-end biotech using single-cell multi-omics, functional assays and machine learning to discover medicines
Founding: Founded Jan 2020 by Charles Roberts, Benjamin Swerner, and Jake Taylor-King
Funding signal: Multiple seed rounds including a $35M seed announced Mar 14, 2024 and larger seed activity through 2024–2025
Headquarters: Regent's Place, 338 Euston Road, London NW1 3BG, UK
Human-focused drug discovery for complex diseases (early indication work includes osteoporosis).
2019
Biotechnology Research
35000000
Seed round announced Mar 14, 2024
25000000
Reported $25M round in June 2022
Seed led by Magnetic Ventures (July 2021) per company timeline
“DCVC, Magnetic Ventures, Khosla Ventures, Firstminute Capital, NVentures, ARK Investment Management, Deerfield Management, NVIDIA, Hitachi Investments, Ark Invest”
| Company |
|---|
About Relation Relation is a technology-enabled biopharmaceutical company developing medicines across immunology, bone diseases and other future indications. The company builds AI and experimental systems to uncover insights into disease biology that transform the path from discovery to patient impact. Relation has raised over $80 million from leading investors including NVIDIA, DCVC, Magnetic, Ark, Deerfield, Khosla Ventures and GSK.
The opportunity As part of Relation’s growing business development function, the Competitive & Portfolio Intelligence Lead will play a pivotal role in shaping how Relation assesses external opportunities and internal pipeline value. This role combines strategic insight, analytical rigour, and scientific understanding to drive decision-making across programmes and therapeutic areas.
You will be responsible for conducting deep market and competitive landscape analysis across therapeutic areas, identifying emerging scientific and clinical trends, and translating those insights into actionable portfolio recommendations. In parallel, you’ll build and interpret DCF and forecast models to support commercial assessments and scenario planning.
By joining Relation, you will become part of an exceptionally talented team with extraordinary leverage to advance the field of drug discovery. Your work will shape our culture, strategic direction, and, most importantly, impact patients’ lives.
Key Responsibilities
Professional background
Personal attributes
Join us in this exciting role where your contributions will have a direct impact on advancing our understanding of genetics and disease risk, supporting our mission to get transformative medicines to patients. Together, we're not just doing research; we're setting new standards in the field of machine learning and genetics. The patient is waiting!
Relation Therapeutics is a committed equal opportunities employer. RECRUITMENT AGENCIES : Please note that Relation Therapeutics does not accept unsolicited resumes from agencies. Resumes should not be forwarded to our job aliases or employees. Relation Therapeutics will not be liable for any fees associated with unsolicited CVs.